FR3573M - Nouveaux médicaments a base d'aryl-5 amino-2 oxadiazoles-1,3,4. - Google Patents

Nouveaux médicaments a base d'aryl-5 amino-2 oxadiazoles-1,3,4.

Info

Publication number
FR3573M
FR3573M FR962579A FR962579A FR3573M FR 3573 M FR3573 M FR 3573M FR 962579 A FR962579 A FR 962579A FR 962579 A FR962579 A FR 962579A FR 3573 M FR3573 M FR 3573M
Authority
FR
France
Prior art keywords
oxadiazoles
aryl
amino
new drugs
drugs based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR962579A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAUSSE LAB
Original Assignee
DAUSSE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR952763A external-priority patent/FR1426091A/fr
Priority claimed from FR962406A external-priority patent/FR1419588A/fr
Application filed by DAUSSE LAB filed Critical DAUSSE LAB
Application granted granted Critical
Publication of FR3573M publication Critical patent/FR3573M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
FR962579A 1963-11-05 1964-02-04 Nouveaux médicaments a base d'aryl-5 amino-2 oxadiazoles-1,3,4. Active FR3573M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR952763A FR1426091A (fr) 1963-11-05 1963-11-05 Phényl-5 diméthylamino-2 oxadiazole 1, 3, 4 et son mode de préparation
FR962406A FR1419588A (fr) 1964-02-03 1964-02-03 Nouveaux aryl-5 amino-2 oxadiazoles-1, 3, 4 et leur mode de préparation

Publications (1)

Publication Number Publication Date
FR3573M true FR3573M (fr) 1965-09-27

Family

ID=86052866

Family Applications (1)

Application Number Title Priority Date Filing Date
FR962579A Active FR3573M (fr) 1963-11-05 1964-02-04 Nouveaux médicaments a base d'aryl-5 amino-2 oxadiazoles-1,3,4.

Country Status (1)

Country Link
FR (1) FR3573M (fr)

Similar Documents

Publication Publication Date Title
FR3821M (fr) Médicament anti-inflammatoire a base de 17,21-orthoester de stéroide.
FR3464M (fr) Médicament agissant sur le systeme nerveux central a base d'azaspiranes.
FR3522M (fr) Médicament a base de benzamides substitués.
FR3434M (fr) Médicaments nouveaux a base de dérivés de benzodiazocine.
FR3475M (fr) Médicament a base de diphényl-amino-éthylamine.
FR2831M (fr) Médicament a base de pancréas.
FR3668M (fr) Médicament a base d'hydrazines substitutées.
FR3573M (fr) Nouveaux médicaments a base d'aryl-5 amino-2 oxadiazoles-1,3,4.
FR3616M (fr) Médicaments a base d'amines cycliques.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR3790M (fr) Nouveaux médicaments a base de 2-alkyl-4-alkylamino-6-alkoxy-s-triazines.
FR3755M (fr) Médicament a base de nouvelles pénicillines.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR3440M (fr) Médicaments nouveaux a base de 10-cis, 12-trans-hexadécadiénol-(1).
FR3193M (fr) Nouveaux médicaments a base de dibenzocycloheptenes substitués.
FR2415M (fr) Médicament a base d'éthanolamines substituées.
FR3232M (fr) Nouveaux médicaments a base de dihydroxynitrate de bismuth.
FR3272M (fr) Médicament a base d'hydrazines substituées.
FR3260M (fr) Médicament a base d'isopropanols.
FR3162M (fr) Médicament a base de sulfapyrimidines.
FR3452M (fr) Composés thérapeutiques a base de nouvelles 1,4-benzodiazépines substituées.
FR2550M (fr) Médicament a action anorexogene a base de phénylhydroxyéthylamines.
FR3847M (fr) Nouveaux sédatifs a base de 3,11-dioxygéné-17-désoxy-androstanes.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR3229M (fr) Médicaments a base de éthynyl-17α méthyl-4 oestratriene-1,3,5(10) ol-17β.